What is Semax?
Semax is a synthetic heptapeptide analogue of ACTH(4-10) developed by the Institute of Molecular Genetics in Russia. It has been approved in Russia for neurological applications and has a rich body of peer-reviewed research supporting its neuroprotective, nootropic, and anxiolytic properties. Semax acts primarily by upregulating BDNF (brain-derived neurotrophic factor) and modulating dopaminergic and serotonergic systems in the central nervous system.
Canadian researchers studying cognitive function, neuroprotection, stroke recovery, and mood regulation work with Semax for its well-documented CNS activity. VELTRIDE supplies Semax 30mg lyophilized powder at ≥98% HPLC purity with Certificate of Analysis, shipped discreetly across Canada from West Kelowna, BC.
Research Highlights
- Upregulates BDNF — studied for cognitive enhancement and neuroplasticity
- Neuroprotective effects in ischemia and stroke models
- Anxiolytic properties — reduces anxiety-related behaviour in animal models
- Improves learning, memory consolidation, and attention in rodent studies
- Anti-inflammatory effects in CNS — reduces neuroinflammation markers
- Approved medical drug in Russia for optic nerve disease and stroke recovery
- Synergistic with Selank in combined nootropic research protocols
Semax vs Selank
Semax is primarily studied for cognitive enhancement and neuroprotection via BDNF upregulation. Selank focuses more on anxiety reduction and immune modulation via enkephalin pathways. Many researchers study the two peptides together for comprehensive nootropic and anxiolytic research protocols.
Related Products
What Researchers Are Saying
"Semax is critical for our BDNF research. VELTRIDE's quality is consistent and ships to BC fast."
— P.B., Surrey BC"Our neuropeptide cognitive research uses VELTRIDE exclusively for Semax in Canada. Excellent."
— T.O., Toronto ON"Reliable Semax peptide source in Canada. Our neurological study data has been very consistent."
— H.D., Edmonton AB